Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tyrberg, B.
Right arrow Articles by Andersson, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tyrberg, B.
Right arrow Articles by Andersson, A.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Diabetes 50:301-307, 2001
© 2001 by the American Diabetes Association, Inc.

Stimulated Endocrine Cell Proliferation and Differentiation in Transplanted Human Pancreatic Islets

Effects of the ob Gene and Compensatory Growth of the Implantation Organ

Björn Tyrberg, Jarkko Ustinov, Timo Otonkoski, and Arne Andersson

From the Department of Medical Cell Biology (B.T., A.A.), Uppsala University, Uppsala, Sweden; the Transplantation Laboratory (J.U., T.O.), Haartman Institute; and the Hospital for Children and Adolescents (T.O.), University of Helsinki, Helsinki, Finland.

Address correspondence and reprint requests to Björn Tyrberg, UCSD Cancer Center, Burnham Institute, 10901 N. Torrey Pines Rd., La Jolla, CA 92037. E-mail: btyrberg{at}ucsd.edu .

Neogenesis is crucial for the maintenance of ß-cell mass in the human pancreas and possibly for the outcome of clinical islet transplantation. To date, no studies have reported a stimulation of human ß-cell neogenesis in vivo. Therefore, we investigated whether human {alpha}-, ß-, and duct cell growth can be stimulated when human islets are xenotransplanted to obese hyperglycemic-hyperinsulinemic ob/ob mice immuno-suppressed with anti-lymphocyte serum. Moreover, we wanted to study whether ß-cell growth and duct-to-ß-cell differentiation were induced in the hepatocyte growth factor (HGF)-dependent compensatory kidney growth model. For that purpose, we evaluated human islets grafted to nude (nu/nu) mice before uninephrectomy of the contralateral kidney for DNA-synthesis and duct cell expression of the ß-cell-specific transcription factor Nkx 6.1 as an estimate of differentiation. Human islet grafts were well preserved after 2 weeks when transplanted to ob/ob mice during anti-lymphocyte immunosuppression. Both human ß-cells (P < 0.01) and duct cells (P < 0.001) were growth stimulated when islets were transplanted to ob/ob mice. We also observed a correlation between increased duct cell proliferation and increased organ donor age (P = 0.02). Moreover, duct (P < 0.05) and ß-cell (P < 0.05) proliferation, as well as duct cell Nkx 6.1 expression (P < 0.05), were enhanced by the compensatory kidney growth after uninephrectomy. We conclude that it is possible to stimulate human ß-cell neogenesis in vivo, provided that the recipient carries certain growth-stimulatory traits. Furthermore, it seems that duct cell proliferation increases with increasing organ donor age. Altogether, these data and previous results from our laboratory suggest that human ß-cell neogenesis becomes more dependent on differentiation and less dependent on proliferation with increasing age.



Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
R. Mussmann, M. Geese, F. Harder, S. Kegel, U. Andag, A. Lomow, U. Burk, D. Onichtchouk, C. Dohrmann, and M. Austen
Inhibition of GSK3 Promotes Replication and Survival of Pancreatic Beta Cells
J. Biol. Chem., April 20, 2007; 282(16): 12030 - 12037.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
W. L. Suarez-Pinzon, J. R. T. Lakey, S. J. Brand, and A. Rabinovitch
Combination Therapy with Epidermal Growth Factor and Gastrin Induces Neogenesis of Human Islet {beta}-Cells from Pancreatic Duct Cells and an Increase in Functional {beta}-Cell Mass
J. Clin. Endocrinol. Metab., June 1, 2005; 90(6): 3401 - 3409.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
G. C. Weir and S. Bonner-Weir
Five Stages of Evolving Beta-Cell Dysfunction During Progression to Diabetes
Diabetes, December 1, 2004; 53(suppl_3): S16 - S21.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
A. E. Butler, J. Janson, W. C. Soeller, and P. C. Butler
Increased {beta}-Cell Apoptosis Prevents Adaptive Increase in {beta}-Cell Mass in Mouse Model of Type 2 Diabetes: Evidence for Role of Islet Amyloid Formation Rather Than Direct Action of Amyloid
Diabetes, September 1, 2003; 52(9): 2304 - 2314.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
R. Gao, J. Ustinov, M.-A. Pulkkinen, K. Lundin, O. Korsgren, and T. Otonkoski
Characterization of Endocrine Progenitor Cells and Critical Factors for Their Differentiation in Human Adult Pancreatic Cell Culture
Diabetes, August 1, 2003; 52(8): 2007 - 2015.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
R. A. Ritzel and P. C. Butler
Replication Increases {beta}-Cell Vulnerability to Human Islet Amyloid Polypeptide-Induced Apoptosis
Diabetes, July 1, 2003; 52(7): 1701 - 1708.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
A. E. Butler, J. Janson, S. Bonner-Weir, R. Ritzel, R. A. Rizza, and P. C. Butler
{beta}-Cell Deficit and Increased {beta}-Cell Apoptosis in Humans With Type 2 Diabetes
Diabetes, January 1, 2003; 52(1): 102 - 110.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2001 by the American Diabetes Association.